HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Finnish Leukemia Group Selected Research

floctafenine

9/2022Efficacy of conventional-dose cytarabine, idarubicin and thioguanine versus intermediate-dose cytarabine and idarubicin in the induction treatment of acute myeloid leukemia: Long-term results of the prospective randomized nationwide AML-2003 study by the Finnish Leukemia Group.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Finnish Leukemia Group Research Topics

Disease

2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
09/2022 - 10/2010
1Leukemia
09/2022
1Infections
10/2010
1Neutropenia
10/2010

Drug/Important Bio-Agent (IBA)

1Cytarabine (Cytosar-U)FDA LinkGeneric
09/2022
1floctafenineIBA
09/2022
1Thioguanine (Tioguanine)FDA Link
09/2022
1Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric
09/2022

Therapy/Procedure

1Induction Chemotherapy
09/2022
1Drug Therapy (Chemotherapy)
10/2010